药物配合饮食干预治疗肺心病患者胃肠功能紊乱疗效观察

摘要

Objective:To investigate the treatment of pulmonary heart disease in patients with of the gastrointestinal tract,and search for effective treatment.Method:From November 2011 to August 2012,the treatment of 440 patients with pulmonary heart disease,which occured in patients with gastrointestinal disorders.The 210 patients were randomly divided into drug treatment group of 70 cases,dietary intervention group of 70 cases and drugs with dietary intervention group of 70 cases .The patients of drug tremt ment group were given intravenous pantoprazole 40 mg +5% 100 ml,the patients of dietary intervention group were given dietary intervention.The patients of drug with dietary interention group were given the treatment programs 1 with 2.Result:The drug group total effective rate was 75.7%,the dietary intervention group total effective rate was 71.4%;drugs with dietary intervention group,the total effective rate was 94.3%.Clinical efficacy of the drug with the diet group was significantly higher than the group with medication and diet intervention group,with a statistically significant difference(P<0.05),in the quality of life,in the evaluation of the project,with the diet group USQL score drugs,treatment dimension,the social dimension,psychological dimensions,physiological dimensions were significantly better than the drug treatment group and the diet intervention group,compared with a statistically significant difference(P<0.05).Conclusion:Drug therapy with diet intervention can effectively improve patients’gastrointestinal function,improve the quality of the patients’life.%　　目的：探讨肺心病患者胃肠道功能紊乱的治疗方法，寻找有效的治疗手段。方法：选择本院2011年11月-2012年8月治疗的440例肺心病患者，其中发生胃肠功能紊乱的患者有210例，随机分为药物治疗组、饮食干预组和药物配合饮食干预组各70例。药物治疗组患者给予泮托拉唑40 mg+5%GS 100 ml 静脉滴注，饮食干预组患者给予饮食干预。药物配合饮食干预组患者给予药物治疗和饮食干预组的治疗方案。结果：药物组总有效率75.7%，饮食干预组总有效率71.4%；药物配合饮食干预组总有效率94.3%。药物配合饮食组的临床疗效明显高于与药物治疗组和饮食干预组，差异有统计学意义（P<0.05），药物配合饮食组在生活质量评价项目中 USQL 总分、治疗维度、社会维度、心理维度、生理维度均明显优于药物治疗组和饮食干预组，比较差异有统计学意义（P<0.05）。结论：通过药物治疗配合饮食干预能有效地改善患者胃肠道功能，提高患者生活质量。